Syntax Bio
Business Services · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 N Aberdeen St Fl 9, Chicago, Illinoi...Website
www.syntax-bio.comRevenue
<$5 MillionIndustry
About Syntax Bio
Syntax Bio Org Chart
Is Syntax Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Syntax Bio recently announced quarterly report
Click to see if Syntax Bio had a recent Job posting/layoffs
Check if Syntax Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if Syntax Bio is spiking on competitors!
Product Launch: Get notified when Syntax Bio launches new products
Funding: Get notified immidiatlly once Syntax Bio has new funding data
Website visits: Recent activity has been detected on your website
Syntax Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Syntax Bio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Syntax Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Syntax Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Syntax Bio.
Syntax Bio financials insights
Gather financial insights about Syntax Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Seed
$4.5M
Series A
$14.4M
Most Recent Scoops
Top Business Services Companies
Frequently Asked Questions Regarding Syntax Bio
Syntax Bio is a Chicago, IL-based preclinical-stage biotechnology company. Co-founded by Ryan Clarke, PhD, and Professor Brad Merrill, PhD, from the University of Illinois at Chicago, Syntax Bio is a preclinical-stage biotechnology company that is focused on generating therapeutic-grade cells from stem cells leveraging its novel Cellgorithm platfor... Read More
